Dr. Nirav Shah, former Maine CDC director, taking post at Colby College
Mar. 13—Dr. Nirav Shah, Maine's former CDC director and a top federal health official during the Biden administration, is returning to Maine to launch a public health education program at Colby College.
Shah, 48, became a mini-celebrity in Maine during the COVID-19 pandemic, when he was often on television and online explaining the coronavirus to the public and answering journalists' questions. Chocolate bars were named after him, coffee mugs were inscribed with the words "In Dr. Shah We Trust," and he enjoyed a large online fan club.
Shah left Maine in 2023 after being tapped by the Biden administration to become principal deputy director of the U.S. Centers for Disease Control and Prevention in Atlanta.
Shah, in an interview with the Press Herald on Tuesday, said it was always his intention to return to Maine, as he and his wife kept their home in Brunswick to return to once his federal stint was over.
"It was a tremendous opportunity," Shah said of the U.S. CDC job, where among other duties, he focused on the federal response to the bird flu. "It was an opportunity to help the CDC think about the big picture and develop a long-term strategy."
Shah said he's excited to help stand up an undergraduate public health program at Colby College in Waterville, where he will be a visiting professor.
"I will be leading an effort to create a public health undergraduate program, and help shape the future of public health training," Shah said. "Interest in public health is as high as it's ever been, especially among young people."
David Greene, Colby College president, said in a written statement that Shah is a "natural teacher."
"He has an extraordinary capacity to synthesize and communicate complex issues. And that he does so with humor, compassion, and a clear commitment to bettering the lives of others is all the more remarkable," Greene said.
Shah helped during the transition from the Biden to the Trump administration, but his last day on the job was Feb. 28.
Shah said he is not discussing what led to his departure at this time — other than changing administrations — or his thoughts on the Trump administration's approach to public health. Shah said he may at a later time make public comments about the Trump administration.
Trump nominated Robert F. Kennedy Jr., an anti-vaccine activist who has made many false claims about vaccines, to oversee the U.S. CDC as health and human services secretary.
Kennedy, in a Fox News interview this week, falsely claimed that the measles vaccine can cause the measles.
This story will be updated.
Copy the Story Link
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
40 minutes ago
- Yahoo
H5N1 bird flu ‘capable of airborne transmission'
H5N1 bird flu is capable of spreading through the air, a new animal study from the US Centres for Disease Control (CDC) has found. H5N1 was believed to spread primarily through direct contact with infected animals or their bodily fluids, but the new findings suggest it can also be transmitted through respiratory droplets and aerosol, raising concerns about its ability to cause a future pandemic. The study, published in Emerging Infectious Diseases, was based on a sample of H5N1 extracted from a dairy worker in Michigan who contracted the virus last year. The CDC scientists then used this sample to infect a group of ferrets, which are considered a 'gold standard' in flu research due to the similarity between their respiratory system and that of human. The infected animals were placed in close proximity to six other healthy ferrets and observed for three weeks. Within 21 days, three of the previously uninfected ferrets had contracted H5N1 – without any direct physical contact – indicating that the virus can travel through the air through a 'respiratory droplet transmission model'. The researchers also collected aerosol samples from the air surrounding the ferrets, and found infectious virus and viral RNA to be present, indicating that H5N1 can, like Covid-19, be transmitted through both respiratory droplets and aerosols – smaller particles that can travel longer distances and remain suspended in the air for extended periods. Respiratory droplets, on the other hand, are larger and do not travel as far in the air, requiring closer contact with an infected person for transmission. Since 2024, at least 70 people in the US have been infected with H5N1, the majority of them workers on poultry or dairy farms where the virus was present. Bird flu has spread to more than 1,000 dairy farms across the country over the past year and is now endemic among US cattle. 'This study is important as it provides yet more evidence that the H5N1 influenza virus that is circulating in dairy cattle in the USA is, in principle, capable of respiratory transmission,' Prof Ed Hutchinson, Professor of Molecular and Cellular Virology, MRC-University of Glasgow Centre for Virus Research told The Telegraph. '[The study] does this using experimental animals that experience and transmit influenza in similar ways to humans, so it warns us of what the virus could do in humans under the right circumstances,' Prof Hutchinson added. The study's authors warned that their findings underline the 'ongoing threat to public health' H5N1 poses, emphasising the need for 'continual surveillance and risk assessment… to prepare for the next influenza pandemic'. Most human cases reported in the US so far have resulted from direct physical contact with sick animals or their fluids, including cow's milk. But experts have warned that, as H5N1 continues to infect animal populations and 'jump' to humans, it is only a matter of time before the virus undergoes the mutations necessary to spread effectively from person to person. 'Because avian H5N1 viruses cross the species barrier and adapt to dairy cattle, each associated human infection presents further opportunity for mammal adaptation,' the study's authors said. Protect yourself and your family by learning more about Global Health Security Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
San Francisco Chronicle
an hour ago
- San Francisco Chronicle
The Latest: Trump heads to Fort Bragg to celebrate 250th anniversary for US Army
President Donald Trump plans to speak at Fort Bragg on Tuesday to celebrate the 250th anniversary of the U.S. Army as he deploys the military in an attempt to quiet immigration protests in Los Angeles. Trump has promoted the Army's anniversary as a reason to hold a military parade in Washington, D.C., on Saturday, which is also his 79th birthday. Trump's Tuesday schedule, according to the White House 12:25 p.m. — Trump will travel to Fort Bragg, North Carolina 2:40 p.m. — Once he arrives, Trump will observe a military demonstration 4:00 p.m. — Trump will deliver remarks to service members, veterans and their families 6:00 p.m. — Trump will travel back to the White House Defense Secretary Pete Hegseth to face Congress for first time since Signal leaks He's expected to field sharp questions from members of Congress about his tumultuous start as Pentagon chief, including his sharing of sensitive military details over a Signal chat, in three separate Capitol Hill hearings beginning Tuesday. Lawmakers also have made it clear they're unhappy that Hegseth hasn't provided details on the administration's first proposed defense budget, which Trump has said would total $1 trillion, a significant increase over the current spending level of more than $800 billion. It will be lawmakers' first chance to ask Hegseth about a myriad of other controversial spending by the Pentagon, including plans to spend hundreds of millions of dollars on security upgrades to turn a Qatari jet into Air Force One and to pour as much as $45 million into a parade recently added to the Army's 250th birthday bash, which happens to coincide with Trump's birthday on Saturday. Kennedy on Monday removed every member of a scientific committee that advises the CDC on how to use vaccines and pledged to replace them with his own picks. Major physicians and public health groups criticized the move to oust all 17 members of the Advisory Committee on Immunization Practices. Kennedy, who was one of the nation's leading anti-vaccine activists before becoming the nation's top health official, has not said who he would appoint to the panel, but said it would convene in just two weeks in Atlanta. Although it's typically not viewed as a partisan board, the entire current roster of committee members were Biden appointees. Trump pushes ahead with his maximalist immigration campaign in face of LA protests Trump made no secret of his willingness to take a maximalist approach to enforcing immigration laws and keeping order as he campaigned to return to the White House. The fulfillment of that pledge is now on full display in Los Angeles. By overriding California's Gov. Gavin Newsom, Trump is already going beyond what he did to respond to Black Lives Matter protests in 2020, when he warned he could send troops to contain demonstrations that turned violent if governors in the states did not act to do so themselves. Trump said in September of that year that he 'can't call in the National Guard unless we're requested by a governor' and that 'we have to go by the laws.' But now, he's moving swiftly to test the bounds of his executive authority in order to deliver on his promise of mass deportations. What remains to be seen is whether Americans will stand by him once it's operationalized nationwide. For now, Trump is betting that they will. Trump heads to Fort Bragg while facing criticism for deploying military at Los Angeles protests Trump plans to speak at Fort Bragg on Tuesday to celebrate the 250th anniversary of the U.S. Army as he deploys the military in an attempt to quiet immigration protests in Los Angeles. Fort Bragg, located near Fayetteville, North Carolina, serves as headquarters for U.S. Army Special Operations Command. Highly trained units like the Green Berets and the Rangers are based there. Defense Secretary Pete Hegseth and Army Secretary Dan Driscoll will also be at Tuesday's event, along with service members, veterans and their families. Trump has promoted the Army's anniversary as a reason to hold a military parade in Washington, D.C., on Saturday, which is also his 79th birthday. Trump, who sees the military as a critical tool for domestic goals, has used the recent protests in Los Angeles as an opportunity to deploy the National Guard and U.S. Marines to quell disturbances that began as protests over immigration raids.
Yahoo
an hour ago
- Yahoo
Why Trump turned against ‘gold standard' mRNA vaccines
President Trump's administration has slammed the brakes on development of messenger RNA (mRNA) vaccines, which proved their lifesaving potential during the COVID-19 pandemic but have come under increasing scrutiny among skeptics of mainstream science. The vaccines marked a breakthrough in medical technology, drastically reducing the timeline for development of targeted vaccines and even showing promise in cancer research. Trump called mRNA the 'gold standard' when he rolled out the first COVID-19 vaccines. But now they are under assault by Trump's Health and Human Services (HHS) secretary, longtime anti-vaccine advocate Robert F. Kennedy Jr., and his allies in the 'make America healthy again' movement. HHS in late May canceled $766 million awarded to Moderna through the Biomedical Advanced Research and Development Authority (BARDA) to develop a potential mRNA vaccine for bird flu. HHS spokesperson Andrew Nixon said of the decision, 'This is not simply about efficacy — it's about safety, integrity, and trust.' 'The reality is that mRNA technology remains under-tested, and we are not going to spend taxpayer dollars repeating the mistakes of the last administration, which concealed legitimate safety concerns from the public,' he added. Unlike traditional vaccines that contain fragments or weakened versions of a virus, mRNA vaccines send messenger ribonucleic acid into cells to teach the immune system to recognize proteins connected to virus cells. According to Joseph Varon, president and chief medical officer of the Independent Medical Alliance (IMA), the concerns for mRNA vaccine skeptics are the expedited timeline and conditions in which the COVID-19 vaccine was approved. 'The biggest concern is that this rushed treatment still remains in use, even under an Emergency Use Authorization in some cases. It needs to be sent back through proper studies and vetting,' Varon told The Hill. 'There needs to be an established database of vaccine injuries that can be accurately quantified with full transparency, without politics or big money pressure influencing the data,' he added. 'There's a growing body of peer-reviewed studies that indicate the spike proteins are causing havoc in certain recipients.' The IMA, previously known as Front Line COVID-19 Critical Care Alliance, launched a campaign in support of Kennedy's nomination to be HHS secretary. The group drew controversy when its founders promoted ivermectin as a 'miracle drug' for COVID-19. Myocarditis, or inflammation of the heart muscle, is of particular concern among mRNA vaccine opponents. An analysis published in 2022 found that myocarditis occurred in about 31.2 cases per 1 million second doses of the Moderna COVID-19 vaccine, or 0.003 percent. Rates of myocarditis are significantly higher among people with COVID-19 infections than immunizations, however. The development of the COVID-19 mRNA vaccine was aided by the Trump administration's Operation Warp Speed, something Trump has boasted about at numerous points. In remarks in December 2020, the same month the first COVID-19 vaccines were deployed, Trump praised Operation Warp Speed's ability to develop a SARS-CoV-2 vaccine at a 'breakneck speed,' adding 'the gold standard vaccine has been done in less than nine months.' Though research on mRNA and its potential uses has been ongoing for decades, use of the vaccines in humans is relatively new. The first mRNA vaccine candidate tested in humans was for rabies in 2013, but it wouldn't be until the COVID-19 pandemic in 2020 that this technology would achieve commercial viability and widespread use. To Kennedy, this is too much of a coincidence. In his book 'The Wuhan Cover-Up: And the Terrifying Bioweapons Arms Race,' published in 2023, Kennedy suggests it was more than just happenstance that allowed for the deployment of Moderna's mRNA technology to coincide with the global pandemic. He pointed to a meeting attended by Dr. Anthony Fauci and former BARDA Director Rick Bright in which the officials met with virologists months before the COVID-19 pandemic broke out. The fact that attendees discussed the need for innovation in influenza research and vaccines became a point of conspiracy online. Kennedy noted that Bright called for something 'completely disruptive, that's not beholden to bureaucratic strings and processes,' writing, '[Bright] hinted that only a global crisis — like a pandemic — could induce government and industry to commit the billions of dollars necessary to create a new generation of 'plug-and-play' mRNA vaccines.' In the conversation Kennedy references, Bright was discussing the challenges of making influenza research 'sexy' for Ph.D. and postdoctoral students, surmising that something 'completely disruptive' would be needed to incite excitement in the field. Proponents of the mRNA technology point to its deployment in the COVID-19 pandemic and its role in reducing transmission as evidence of safety and efficacy. 'In the U.S., you know, we have a lot of real-world experience now with huge numbers of doses given. We have been following for significant or serious adverse events for a long time, and the rate of those serious adverse events is on par with what we see for other vaccines,' E. John Wherry, director of the Institute for Immunology and Immune Health at the University of Pennsylvania, said of mRNA vaccines. As Wherry notes, all vaccines have adverse side effects, but their safety compared with the diseases they inoculate against is 'incontrovertible.' And while critics take issue with the speed at which mRNA vaccines are developed, Wherry said this difference is precisely what sets these shots apart from older generations. 'mRNA vaccines have a couple of key benefits or features that really stand out compared to other vaccine platforms. One, they can be generated very, very quickly. So, you can adapt to changes very rapidly. This is much easier with an mRNA vaccine, where the COVID strain or flu strain mutates and changes from year to year,' Wherry said. 'The second is that it's relatively simple. So, we don't have to worry about, you know, impurities in, you know, an egg-grown vaccine or a cell-based grown vaccine synthesizing mRNA. There are very few components that go into it, and it can be synthesized with high purity.' Such mRNA vaccines are also potentially applicable for numerous conditions or even multiple different strains of the same virus, giving it more flexibility than traditional vaccinations. 'So, there are substantial benefits in flexibility, in speed, in simplicity of manufacturing and that probably also affects the cost of goods at the end of the day, which is perhaps a last advantage,' Wherry added. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
